September 20, 2010 - Interim six-month results for a stent system designed to treat bifurcation lesions will be presented during the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference in Washington, D.C.
September 20, 2010 – Transcatheter ventricular assist device (VAD) company Abiomed will highlight its devices at several events during the 2010 Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, Sept, 21-25, at the Washington Convention Center in Washington, D.C.
September 20, 2010 – Patient enrollment has started in the EXCELLA BD Randomized Clinical Trial designed to evaluate Elixir Medical’s novolimus-eluting coronary stent with bioabsorbable coating, the Elixir DESyne BD. The first cases were enrolled by professor Joachim Schofer from the Universitäres Herz-und Gefä?zentrum in Hamburg, Germany, and Dr. Karl E.
September 20, 2010 - A new intravascular ultrasound (IVUS) coronary imaging system integrating plaque spectroscopy to better guide therapy will be highlighted during the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting.
September 17, 2010 - The Food and Drug Administration (FDA) cleared the first device that combines an angioplasty balloon and an embolic capturing feature. Angioslide's Proteus device is presently indicated for use in the lower limbs during Percutaneous Transluminal Angioplasty (PTA) procedures.
September 17, 2010 - An aortic valve has been successfully implanted in the acute porcine model by Transcatheter Technologies GmbH (TT) using its Trinity system.
The acute in vivo study of the system has shown:
• Accurate stepwise positioning of Trinity via an antegrade transapical approach.
September 17, 2010 - The Cardiovascular Research Foundation's 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) symposium, to be held Sept. 21- 25, will feature presentations on Xience V data.
September 17, 2010 – The U.S. Food and Drug Administration (FDA) today expanded the indication for three cardiac resynchronization therapy defibrillators (CRT-D) to all classes of heart failure patients.
